Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 557

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Weiss, Raul, Knight, Bradley P., Gold, Michael R., Leon, Angel R., Herre, John M., Hood, Margaret, Rashtian, Mayer, Kremers, Mark, Crozier, Ian, Lee, Kerry L., Smith, Warren, Burke, Martin C.·2013·Circulation

Abstract

Background—: The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter-defibrillator (S-ICD) has been developed as an alternative system. This study evaluated the safety and effectiveness of the S-ICD System (Cameron Health/Boston Scientific) for the treatment of life-threatening ventricular arrhythmias (ventricular tachycardia/ventricular fibrillation). Methods and Results—: This prospective, nonrandomized, multicenter trial included adult patients with a standard indication for an ICD, who neither required pacing nor had documented pace-terminable ventricular tachycardia. The primary safety end point was the 180-day S-ICD System complication-free rate compared with a prespecified performance goal of 79%. The primary effectiveness end point was the induced ventricular fibrillation conversion rate compared with a prespecified performance goal of 88%, with success defined as 2 consecutive ventricular fibrillation conversions of 4 attempts. Detection and conversion of spontaneous episodes were also evaluated. Device implantation was attempted in 321 of 330 enrolled patients, and 314 patients underwent successful implantation. The cohort was followed for a mean duration of 11 months. The study population was 74% male with a mean age of 52±16 years and mean left ventricular ejection fraction of 36±16%. A previous transvenous ICD had been implanted in 13%. Both primary end points were met: The 180-day system complication-free rate was 99%, and sensitivity analysis of the acute ventricular fibrillation conversion rate was >90% in the entire cohort. There were 38 discrete spontaneous episodes of ventricular tachycardia/ventricular fibrillation recorded in 21 patients (6.7%), all of which successfully converted. Forty-one patients (13.1%) received an inappropriate shock. Conclusions—: The findings support the efficacy and safety of the S-ICD System for the treatment of life-threatening ventricular arrhythmias. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01064076.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.003042

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 557

Metadata

Authors
Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., Smith, W., & Burke, M. C.
Venue
Circulation
Published
2013-08-27
Volume
128
Issue
9
Pages
944-953
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2116287860
Cited by
557
References
3
FWCI
33.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator. https://app.cochat.ai/papers/10.1161/circulationaha.113.003042
The paper
Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., Smith, W., & Burke, M. C. (2013). Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator. Circulation. https://doi.org/10.1161/circulationaha.113.003042

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.